GLP Watchdog
The RegisterSemaglutideTirzepatidePeptidesEnforcement
GLP Watchdog

Independent · Not a government agency

We publish who is allowed to sell GLP‑1s in America, what they actually charge once the billing cycle is applied, and the date we last checked.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

The Register

  • All sellers
  • Seller reviews
  • By pharmacy
  • By drug
  • By state
  • By insurance

Enforcement

  • FDA warning letters
  • Peptide sellers
  • Conditions treated
  • Our corrections

Real prices

  • Live price tracker
  • Unit converter
  • Interaction checker
  • Employer coverage
  • All tools

How we check

  • Methodology
  • Editorial policy
  • How we make money
  • Sources
  • Research
  • Glossary
  • FAQ
  • Site index

Who we are

  • About
  • Editorial team
  • Contact
  • Press
  • Advertise
  • Careers
  • Medical Disclaimer
  • Nature of Reviews
  • Disclosure
  • Code of Conduct
  • Privacy
  • Terms
  • Trademarks

GLP Watchdog is an independent publisher. It is not a government agency, a regulator, or a licensing body, and nothing here is an official determination. The information on this site is for general information only and is not a substitute for professional medical advice, diagnosis, or treatment. Wegovy®, Ozempic®, Rybelsus® and Saxenda® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. All other product names referenced are trademarks of their respective owners. GLP Watchdog is not affiliated with any pharmaceutical manufacturer.

© 2026 GLP Watchdog. All rights reserved.